Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now indicates that recruitment is no longer open to participants and adds new Help/Navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment label and updates the revision note to v3.6.0.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new build of the page.SummaryDifference0.0%

- Check30 days agoChange DetectedThe study document revision was updated to v3.5.4, replacing the previous v3.5.3. This reflects a newer version of the protocol without additional visible content changes in the data provided.SummaryDifference0.0%

- Check45 days agoChange DetectedThe location entry has been updated from Taoyuan District, Taiwan, 33305 to Taoyuan, Taiwan, 33305 in the Locations section. This clarifies the city designation for that site in the ATHENA study record.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page shows a Revision tag updated to v3.5.3, indicating a software revision. The study details and visible content appear unchanged.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page footer revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.